| Title: |
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanoma |
| Authors: |
Hieken, Tina J. a; Zahrieh, David b; Flotte, Thomas J. c; Dronca, Roxana S. d; Domingo-Musibay, Evidio e; Nelson, Garth D. b; Strand, Carrie A. b; Kottschade, Lisa A. f; Montane, Heather N. f; Piltin, Mara A. a; Chen, Ruqin g; McWilliams, Robert R. f; Jakub, James W. h; Khariwala, Samir S. i; Dudek, Arkadiusz Z. f; Johnson, Jeffrey E. a; Markovic, Svetomir N. f; Dimou, Anastasios f; Tasche, Kendall K. j; Block, Matthew S. f, ⁎ |
| Source: |
In European Journal of Cancer 9 September 2025 227 |
| Database: |
ScienceDirect |